Navigation Links
Takeda Pharmaceuticals Establishes $3 Million Endowment with AGA Foundation
Date:5/17/2008

Gift Will Fund Annual James W. Freston Single Topic Conference Series for

Gastroenterology Research

BETHESDA, Md., May 17 /PRNewswire/ -- The American Gastroenterological Association (AGA) Foundation for Digestive Health and Nutrition (FDHN) announced a gift of $3 million from Takeda Pharmaceuticals to establish The Takeda Endowment Fund within the AGA Foundation's overall endowment. Interest earned from The Takeda Endowment Fund will provide annual support for an AGA Institute Single Topic Conference. The annual conference will be named in honor of former AGA President and past AGA Foundation Chair, James W. Freston, MD, PhD.

"This contribution will make the science of gastroenterology stronger," said AGA FDHN Chair, Sidney Cohen, MD. "We are extraordinarily pleased and appreciative of Takeda's philanthropic investment in the field of gastroenterology. This endowment grant differs from education grants, which while very important, usually represent support for a single event or project. The Takeda Endowment Fund will provide support for the James W. Freston Conferences in perpetuity. Consequently, we are very excited about the long-term positive health outcomes that The Takeda Endowment Fund will foster."

The purpose of the James W. Freston Single Topic Conference is to bring together scientists in the gastrointestinal field to discuss important scientific issues relevant to the practice of gastroenterology. Conference topics will be identified by the Governing Board of the AGA Institute and conference directors will be world-recognized AGA members and scientific leaders within the specialty. Because understanding of basic concepts in medical science often precedes advances in translational research and improvements in patient care, The Takeda Endowment Fund will support efforts to improve patient health in the years ahead.

"Single topic conferences are cutting-edge opportunities to foster discussion, engag
'/>"/>

SOURCE American Gastroenterological Association Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dr. Keith Wilson Named President and Chief Scientific Officer of Takeda San Diego
2. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
3. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
4. Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
5. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)...   Niagara Thermal Products is proud to announce ... LLC ("B3") as the critical thermal component supplier in ... Army Corps of Engineers.  B3 has developed the only ... and destroys VOCs and other chemical pollutants, allergens and ...
(Date:1/15/2014)... England and SAN JOSE, California ... international biotechnology company developing antibody-drug conjugates for cancer, today announced ... Board of Directors. Dr Reynolds has over 20 years, development ... Medical Officer at Seattle Genetics. "I am delighted ...
(Date:1/15/2014)... , January 15, 2014 A study ... races on the Formula 1 track could help to tackle ... Applied Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) ... healthcare provider Simplyhealth. Telemetry technology, which is inspired ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent ... viruses is the Epstein Barr Virus (EBV), and one of ... a chronic inflammatory disease that destroys the body’s joints. As ... have high concentrations of EBV DNA in their bodies (1). ...
Breaking Biology Technology:Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... , , , , ... at 1 p.m. EDT, Sunday, Aug. 23, to discuss new science experiments ... from NASA,s Kennedy Space Center in Florida and will be broadcast live ... ) , , Media are invited to ...
... Md., Aug. 20 Martek Biosciences Corporation (Nasdaq: MATK ... supply agreement with Milk Powder Solutions, based in Australia. Under the ... exclusive supplier for all of its ARA needs for infant formula ... , , "This new agreement with Milk Powder ...
... - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI ; ... Option(TM) Inferior Vena Cava (IVC) Filter in the United ... limited pre-launch in July. Angiotech holds exclusive worldwide rights ... it obtained in a license agreement with privately held ...
Cached Biology Technology:NASA Sets Briefing on New Space Station Science Experiments 2Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions 2Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions 3Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 2Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 3Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 4Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States 5
(Date:7/9/2014)... cooks are turning to more healthful alternatives to their ... sometimes mean low satisfaction. Now researchers are reporting new ... that are made with olive oil rather than pork ... of Agricultural and Food Chemistry . , Ana M. ... to expect just the right amount of chewiness and ...
(Date:7/9/2014)... fossil from China challenges the commonly held belief that ... ability to fly. The birdlike fossil is actually not ... remains of a tiny tree-climbing animal that could glide, ... in Blanding, Utah, and Alan Feduccia of the University ... Journal of Ornithology . , The fossil of the ...
(Date:7/9/2014)... developed by researchers at the NIH,s National ... its collaborators to treat sickle cell disease ... business. The drug candidate, Aes-103, is the ... molecular mechanism of sickle cell disease. Baxter ... required for regulatory approval and commercialization. , ...
Breaking Biology News(10 mins):Researchers declassify dinosaurs as being the great-great-grandparents of birds 2First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4
... announced a partnership with Toyota to support efforts ... of the Philippines Peablanca Protected Landscape and Seascape ... of the nations main islands. In addition ... additional benefits from agroforestry projects under the three-year ...
... Questions remain unresolved as to whether the Neanderthals ... or because of deteriorating climatic conditions. Although scientists ... has been difficult to pinpoint the climatic character ... new study by an international team of researchers, ...
... This release is available in German . , ... the climate and ecosystem of the Arctic Ocean,Bremerhaven, September 13, ... one metre thick this year, equating to an approximate 50 ... the initial results from the latest Alfred-Wegener-Institute for Polar and ...
Cached Biology News:Conservation International and Toyota partner to protect Philippines' rain forests 2Conservation International and Toyota partner to protect Philippines' rain forests 3Climate -- no smoking gun for Neanderthals 2The sea ice is getting thinner 2The sea ice is getting thinner 3The sea ice is getting thinner 4
... COOLSCOPE is an integrated digital microscope and ... computer, equipment setup, optical adjustment or software ... innovative technology, COOLSCOPE combines simplicity and advanced ... COOLSCOPE offers simultaneous viewing of a macro ...
... kit provides complete components including positive ... detection of DNA fragmentation in cultured ... of BrdU in the procedure provides ... methods. Results can be analyzed by ...
... Life Science LAS-3000 imaging system combines ... simplified user interface, providing significantly improved ... of modularities. The system is especially ... perfect standard system for Western blotting ...
... Science LAS-3000mini is a compact image ... applications, and the perfect standard system ... LAS-3000 provides significantly improved system sensitivity ... calibration standards validate that Fujis LAS-3000 ...
Biology Products: